Association of hemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome.
D000328:Adult; D005260:Female; D006470:Hemorrhage / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010314:Partial Thromboplastin Time; D010547:Persistent Fetal Circulation Syndrome / Q000150:complications* / Q000209:etiology; D010672:Phenytoin / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D011517:Prothrombin Time; D012640:Seizures / Q000150:complications / Q000188:drug therapy; D013577:Syndrome; D014812:Vitamin K / Q000627:therapeutic use
D014812:Vitamin K; D010672:Phenytoin